Navigation Links
Industry and academic researchers gather for innovative accelerating cancer cures research symposium
Date:3/4/2013

Cambridge, MA (March 4, 2013) Today, the Damon Runyon Cancer Research Foundation held its annual Accelerating Cancer Cures Research Symposium designed to foster communication and collaboration between cancer researchers in industry and academia to speed progress against cancer. Hosted by Millennium: The Takeda Oncology Company, the meeting included physician-scientists from Eli Lilly and Company, ARIAD, Celgene, Genentech, Merck, and Pfizer, as well as academic researchers from the top universities and research institutions in the nation.

Accelerating Cancer Cures is a unique collaboration between Damon Runyon, a prestigious cancer charity that supports the most innovative young cancer researchers, and leading biopharmaceutical companies. The goal of this multi-million dollar initiative is to rebuild the ranks of specially trained physician-scientists who conduct both the cutting-edge laboratory research to identify new therapeutics, as well as the clinical trials to bring these new treatments to patients. The companies involved in this initiative, while competitors in the marketplace, are committed to supporting the best young clinical investigators so that they can drive the next breakthroughs in cancer prevention, diagnosis and treatment.

The President and CEO of Millennium, Dr. Deborah Dunsire, opened the meeting with remarks that focused on the need for greater collaboration between industry and academia. Additionally, David Nathan, MD, President Emeritus, Dana-Farber Cancer Institute, and the Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School, delivered a keynote address about the promise of cancer research and the critical role of patient-oriented physician-scientists in advancing progress against the many forms of cancer. Richard B. Gaynor, MD, Vice President, Cancer Research/Clinical Investigation, of Lilly, and Alan Leventhal, Chairman and CEO of Beacon Capital Partner
'/>"/>

Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MSU invention could help pharmaceutical industry save money
2. More cutting-edge cancer research supported by industry
3. Ultra-short laser pulses for science and industry
4. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
5. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
6. Advertising Industry Veteran Pat McCrossan Joins Mangos
7. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
8. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
9. A Void In The Independent Pharmacy Industry Leads to Independent Rx Consulting, Powered by OurHelix
10. Massage Industry Heavyweights Team Up for First-Ever Massage Documentary
11. Butter flavoring in microwave popcorn, thought safe for food industry workers, is respiratory hazard
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... 25, 2014 Recently, LunaDress.co.uk has updated its blog ... related accessories. Now, all of the models at LunaDress.co.uk come with ... groom lifts the wedding veil can turn out to be a ... A wedding veil can always bring surprise to a wedding. On ... how to choose veils for a big day . , ...
(Date:12/25/2014)... (HealthDay News) -- The risk of burns from fires ... need to be extra cautious, an expert says. ... significant increase in patients coming in with burns," said ... Volunteer Firefighters Burn Center of Stony Brook University Hospital ... of joy, but if not careful, could quickly turn ...
(Date:12/25/2014)... News) -- Among early stage breast cancer patients who ... one percent will eventually develop leukemia as a result ... finding comes from a review of more than 20,000 ... it suggests that the risk for developing treatment-related leukemia, ... thought. "The frequency of bone marrow cancers such ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... offers formulas of essential prenatal ... ... Mission Pharmacal today announced,the launch of the CitraNatal(TM) family of ... of essential vitamins,and minerals for women prior to conception, throughout ...
... an,entrepreneur trained in Pilates, is bringing the latest Pilates ... Element Pilates.,Ilitch,s version of the innovative barre workout is ... and dance exercises,in rapid sequence to tone and transform ... any other studios in the area. According to ...
... on Cold and ... ... a division of,American Scientific Resources (Pink Sheets: ASFX), today announced the,launch ... world, now available at Walgreens Stores,nationwide and online at http://www.kidzmed.com ...
... health care system is one of only five organizations ... DIEGO, Nov. 20 President,George W. Bush and Commerce ... five organizations to receive the 2007 Malcolm,Baldrige National Quality ... performance excellence. (Photo: http://www.newscom.com/cgi-bin/prnh/20071120/DC07985-a ...
... Jewelers returns to national campaign for fourth year to support ... in communities everywhere., AKRON, Ohio, Nov. 20 Kay ... off its annual Thanks and Giving,campaign. This is the fourth ... has partnered with St. Jude in fundraising campaigns. Thanks ...
... Eularis WHAT: Presentation on Marketing Return: What can be ... WHEN: 26 November 2007 at 2:30 p.m. GMT, WHERE: Pharmaceutical ... ... and LONDON, Nov. 20 Dr. Andree Bates,president of the pharmaceutical analytics company ...
Cached Medicine News:Health News:Mission Pharmacal Launches CitraNatal(TM) Prescription Prenatal Vitamin Line 2Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 2Health News:Ilitch Brings New Brand of Pilates to Metro Detroit With Opening of Studio in West Bloomfield 3Health News:World's First Non-Contact Thermometer for Children Now Available at Walgreens Nationwide 2Health News:World's First Non-Contact Thermometer for Children Now Available at Walgreens Nationwide 3Health News:Sharp HealthCare Receives 2007 Presidential Award for Quality and Performance Excellence 2Health News:Sharp HealthCare Receives 2007 Presidential Award for Quality and Performance Excellence 3Health News:Kay Jewelers Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks and Giving(R) Campaign 2Health News:Kay Jewelers Joins St. Jude Children's Research Hospital(R) to Kick Off Fourth Annual Thanks and Giving(R) Campaign 3Health News:MEDIA ALERT: Eularis to Address Marketing Return at Pharmaceutical Marketing Society Half-day Conference: ROI or RIP? 2
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... support to healthcare providers for behavioral health and ... secured $30 million in equity financing from new ... Drosos , President and Chief Executive Officer. ... and development of Assurex Health,s GeneSight ® ...
(Date:12/24/2014)... 2014 In response to urgent requests from the Deputy ... Sierra Leone , Direct Relief delivered two 10-bed medical ... treatment of local health workers who contract Ebola while fighting ... care center was constructed for foreign health care workers who ... for local Sierra Leonean health workers. With ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... Switzerland, Jan. 9 ESBATech AG, a leading developer ... of the Phase I/IIa clinical development of its ... This double-blind, randomized, placebo-controlled Phase I/IIa clinical study ... efficacy on pain with ESBA105 applied locally via ...
... transplantation to be Quark,s second indication with ... Calif., Jan. 8 Quark Pharmaceuticals, Inc., ... novel RNA interference (RNAi)-based therapeutics, today announced ... its Phase I/II clinical trial evaluating its ...
Cached Medicine Technology:ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 2ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 3ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity 4Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 2Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 3Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function 4
MISTY OX® Gas Injection Nebulizer (GIN)...
... OMNI~NEB delivers breakthrough continuous low-flow ... and precise nozzle technology allows for ... with or without Heliox). OMNI~NEB takes ... in both routine and critical care ...
... Raindrop® medication nebulizer achieves optimum lung penetration ... size range is 1.04-1.10 µ at 6-8 ... air outlet., ,As the world leader ... providers the assurance of proven technology by ...
Reliable and Affordable. The Schuco 3000 Nebulizer by Allied has been designed to offer a compact style that provides worry-free affordable nebulizer therapy....
Medicine Products: